Found: 1697
Select item for more details and to access through your institution.
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 6146, doi. 10.1002/alz.14096
- By:
- Publication type:
- Article
Longitudinal plasma phosphorylated‐tau217 and other related biomarkers in a non‐demented Alzheimer's risk‐enhanced sample.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 6183, doi. 10.1002/alz.14100
- By:
- Publication type:
- Article
Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 6008, doi. 10.1002/alz.14065
- By:
- Publication type:
- Article
CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 5819, doi. 10.1002/alz.13862
- By:
- Publication type:
- Article
A prospective feasibility trial exploring novel biomarkers for neurotoxicity after isolated limb perfusion.
- Published in:
- Perfusion, 2024, v. 39, n. 8, p. 1657, doi. 10.1177/02676591231213506
- By:
- Publication type:
- Article
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01593-7
- By:
- Publication type:
- Article
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 15, p. 1245, doi. 10.1001/jama.2024.13855
- By:
- Publication type:
- Article
CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 6860, doi. 10.1002/alz.14152
- By:
- Publication type:
- Article
CSF Biomarkers.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1180, n. 1, p. 28, doi. 10.1111/j.1749-6632.2009.04944.x
- By:
- Publication type:
- Article
Expanding the cerebrospinal fluid endopeptidome.
- Published in:
- Proteomics, 2017, v. 17, n. 5, p. 1, doi. 10.1002/pmic.201600384
- By:
- Publication type:
- Article
Brain Neuropeptidergic Function in Suicide Victims.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 1996, v. 11, n. 6, p. 451, doi. 10.1002/(SICI)1099-1077(199611)11:6<451::AID-HUP812>3.0.CO;2-#
- By:
- Publication type:
- Article
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
- Published in:
- Archives of Toxicology, 2020, v. 94, n. 7, p. 2517, doi. 10.1007/s00204-020-02755-w
- By:
- Publication type:
- Article
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.
- Published in:
- NPJ Aging, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41514-023-00114-4
- By:
- Publication type:
- Article
A sex-stratified analysis of neuroimmune gene expression signatures in Alzheimer's disease brains.
- Published in:
- GeroScience, 2023, v. 45, n. 1, p. 523, doi. 10.1007/s11357-022-00664-7
- By:
- Publication type:
- Article
Towards compendia of negative genetic association studies: an example for Alzheimer disease.
- Published in:
- Human Genetics, 2006, v. 119, n. 1/2, p. 29, doi. 10.1007/s00439-005-0078-9
- By:
- Publication type:
- Article
Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease.
- Published in:
- Human Genetics, 2004, v. 114, n. 6, p. 581, doi. 10.1007/s00439-004-1107-9
- By:
- Publication type:
- Article
Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease.
- Published in:
- Human Genetics, 2004, v. 114, n. 5, p. 478, doi. 10.1007/s00439-004-1093-y
- By:
- Publication type:
- Article
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01119-4
- By:
- Publication type:
- Article
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0777-4
- By:
- Publication type:
- Article
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
- Published in:
- Translational Psychiatry, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41398-023-02706-w
- By:
- Publication type:
- Article
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic.
- Published in:
- Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02558-4
- By:
- Publication type:
- Article
Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67232-1
- By:
- Publication type:
- Article
High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1106028
- By:
- Publication type:
- Article
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 5, p. 719, doi. 10.1007/s13365-020-00889-2
- By:
- Publication type:
- Article
Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 6, p. 695, doi. 10.1007/s13365-018-0664-y
- By:
- Publication type:
- Article
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
- Published in:
- Journal of NeuroVirology, 2017, v. 23, n. 1, p. 106, doi. 10.1007/s13365-016-0466-z
- By:
- Publication type:
- Article
The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
- Published in:
- International Journal of Geriatric Psychiatry, 2010, v. 25, n. 4, p. 403
- By:
- Publication type:
- Article
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01168-y
- By:
- Publication type:
- Article
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01142-0
- By:
- Publication type:
- Article
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01110-8
- By:
- Publication type:
- Article
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01101-9
- By:
- Publication type:
- Article
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01108-2
- By:
- Publication type:
- Article
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01094-5
- By:
- Publication type:
- Article
Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01021-8
- By:
- Publication type:
- Article
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01014-7
- By:
- Publication type:
- Article
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-00990-0
- By:
- Publication type:
- Article
Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01011-w
- By:
- Publication type:
- Article
The accuracy and robustness of plasma biomarker models for amyloid PET positivity.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-021-00942-0
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Prodromal frontotemporal dementia: clinical features and predictors of progression.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00932-2
- By:
- Publication type:
- Article
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00895-4
- By:
- Publication type:
- Article
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00875-8
- By:
- Publication type:
- Article
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00875-8
- By:
- Publication type:
- Article
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00895-4
- By:
- Publication type:
- Article
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00827-2
- By:
- Publication type:
- Article
The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer's disease patients.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00903-7
- By:
- Publication type:
- Article
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00886-5
- By:
- Publication type:
- Article
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuum.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00878-5
- By:
- Publication type:
- Article